Previous studies confirmed that HMGB1 could upregulate the ERK1/2 pathway in CRC, and Wnt and ERK signaling pathways were activated by HMGB1 in pancreatic cancer [27, 33]. Here, MAPK3 is linked to colorectal carcinoma.